Biomarkers, Tumor

"Biomarkers, Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS.

Descriptor ID	D014408
MeSH Number(s)	D23.101.140
Concept/Terms	Biomarkers, Tumor Biomarkers, Tumor Tumor Biomarkers Markers, Biological Tumor Tumor Markers, Biological Markers, Tumor Metabolite Tumor Metabolite Markers Metabolite Markers, Tumor Marker, Tumor Metabolite Metabolite Marker, Tumor Tumor Metabolite Marker Tumor Markers, Biologic Biologic Tumor Markers Markers, Biologic Tumor Marker, Biologic Tumor Biologic Tumor Marker Tumor Marker, Biologic Biochemical Tumor Markers Markers, Biochemical Tumor Marker, Biochemical Tumor Biochemical Tumor Marker Tumor Marker, Biochemical Tumor Markers, Biochemical Carcinogen Markers Markers, Carcinogen Markers, Neoplasm Metabolite Neoplasm Metabolite Markers Marker, Neoplasm Metabolite Metabolite Marker, Neoplasm Neoplasm Metabolite Marker Metabolite Markers, Neoplasm Biological Tumor Markers Biological Tumor Marker Tumor Marker, Biological Marker, Biological Tumor Markers, Tumor Markers, Tumor Tumor Markers Biomarkers, Cancer Cancer Biomarkers

Below are MeSH descriptors whose meaning is more general than "Biomarkers, Tumor".

Chemicals and Drugs [D]
Biological Factors [D23]
Biomarkers [D23.101]
Biomarkers, Tumor [D23.101.140]

Below are MeSH descriptors whose meaning is related to "Biomarkers, Tumor".

Below are MeSH descriptors whose meaning is more specific than "Biomarkers, Tumor".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Biomarkers, Tumor" by people in this website by year, and whether "Biomarkers, Tumor" was a major or minor topic of these publications.

Bar chart showing 413 publications over 31 distinct years, with a maximum of 30 publications in 2014

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	1	2
1997	2	0	2
1998	2	0	2
1999	1	1	2
2000	0	2	2
2001	3	0	3
2002	5	3	8
2003	5	3	8
2004	5	8	13
2005	8	4	12
2006	4	3	7
2007	9	5	14
2008	10	7	17
2009	6	6	12
2010	7	6	13
2011	9	15	24
2012	11	9	20
2013	9	14	23
2014	21	9	30
2015	17	6	23
2016	8	14	22
2017	10	6	16
2018	13	9	22
2019	17	11	28
2020	10	10	20
2021	12	7	19
2022	0	7	7
2023	0	5	5
2024	7	6	13
2025	8	7	15
2026	5	4	9

Below are the most recent publications written about "Biomarkers, Tumor" by people in Profiles.

Garg A, Mannheimer JD, Gardner H, London CA, Hendricks WPD, Wang G, Day K, Sakthikumar S, Warrier M, Mazcko C, Beck JA, LeBlanc AK. Integrated Multiomic Profiling Enhances Risk Stratification and Prognostication in Canine Osteosarcoma. Clin Cancer Res. 2026 Aug 14; 32(16):3668-3682.

View in: PubMed
Cui W, Xiao H, Wen X, Li C, Bao S, Long Y, Yang X, Wang K, Guo Q, Huang J. CEMs-SELEX: DNAzyme-powered de novo biomarker discovery and noninvasive cancer diagnosis. Sci Adv. 2026 May 29; 12(22):eaee7184.

View in: PubMed
Bledsoe JR, Ferry JA, Li J, Sassoon A, Stonhill MA, Siegele B, Liang X, Dalton J, Mochel MC, Ivashkevich Y, Johari V, Sadigh S, Selove W, Sood S, Ward N, Woda B, Degar B, Feraco AM, Rowe J, Davies K, Al-Ibraheemi A, Amador C, Kovach AE, Fleming MD, Harris MH, Tsai HK. Recurrent SWI/SNF Deficiency Defines a Subset of Peripheral T-Cell Lymphoma With Distinct Clinicopathologic Features. Mod Pathol. 2026 Jul; 39(7):101015.

View in: PubMed
Steiner D, Sultan L, Sullivan T, Liu H, Xiao X, LeClerc A, Melvin S, Alekseyev YO, Liu G, Mazzilli SA, Zhang J, Suzuki K, Rieger-Christ K, Burks EJ, Beane J, Lenburg ME. Vascular invasion-associated gene expression is detectable in pre-surgical biopsies of stage I lung adenocarcinoma. Nat Commun. 2026 Mar 24; 17(1).

View in: PubMed
Rao K, Rao Z, Huang A, Heston S, Wang M, Yildiz-Altay ?, Qutab F, Kwong DA, Gardner HL, Richmond JM, London CA. Peripheral blood mononuclear cell gene expression signatures predict long-term survivorship in canine DLBCL. Sci Rep. 2026 Mar 17; 16(1).

View in: PubMed
Qu W, Jia J, Zhang N, Wang R, Liu Y, Zhang S, Gao H, Tao Y, Jia L, Liu Y, Zhao J. Oncogenic role of PHF23 in gastric cancer progression. Funct Integr Genomics. 2026 Mar 04; 26(1).

View in: PubMed
Ribas-Filho JM, N Doelken E, Tripathi S, Polat B, Lissner R, B?eldicke T, Ribas CAPM, Malafaia O, Gasser M, Waaga-Gasser AM. ALDH1 and ALCAM as emerging biomarkers in personalized rectal cancer therapy. Arq Bras Cir Dig. 2026; 38:e1920.

View in: PubMed
Tang X, Liu L, Gao M, Duan P, Li S, Yuan Z, Xia Q, Xi L, Tan Y. Single-cell transcriptomics identifies fibroblast associated immune heterogeneity and prognostic signatures in bladder cancer. Sci Rep. 2026 Feb 03; 16(1):7151.

View in: PubMed
Falc?-Roget J, Basile GA, Janus A, Lillo S, Politi LS, Argasinski JK, Cacciola A. A non-local diffusion magnetic resonance imaging tract density biomarker to stratify, predict, and interpret survival rates in human glioblastoma. Neuro Oncol. 2026 Feb 01; 28(2):564-579.

View in: PubMed
Ribas CAPM, N Doelken E, Tripathi S, Polat B, Lissner R, B?eldicke T, Ribas-Filho JM, Malafaia O, Gasser M, Waaga-Gasser AM. Prognostic and predictive value of AXL and C-MET in patients with rectal cancer. Arq Bras Cir Dig. 2026; 38:e1918.

View in: PubMed

People

Explore

Similar Concepts

Top Journals